Analyst Reco. CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 00:00:03 16/05/2026 +04			5-day change	1st Jan Change
95.89 ^USD	-1.30%		+5.90%	+20.83%

05-15	Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health	RE
05-14	Cvs Health® and Wgu launch online pre-pharmacy degree program for future pharmacists nationwide	RE

Analyst Reco.

05-14	Morgan Stanley Adjusts Price Target on CVS Health to $106 From $93, Maintains Overweight Rating	MT
05-14	Argus Adjusts Price Target on CVS Health to $104 From $90, Maintains Buy Rating	MT
05-12	Bernstein Adjusts CVS Health Price Target to $106 From $94, Maintains Outperform Rating	MT
05-12	JPMorgan Adjusts Price Target on CVS Health to $111 From $101, Maintains Overweight Rating	MT
05-11	TD Cowen Adjusts Price Target on CVS Health to $110 From $105	MT
05-07	CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says	MT
05-07	UBS Adjusts Price Target on CVS Health to $100 From $97, Maintains Buy Rating	MT
05-07	RBC Capital Adjusts CVS Health Price Target to $107 From $93, Maintains Outperform Rating	MT
05-07	Deutsche Bank Adjusts CVS Health Price Target to $92 From $88, Maintains Buy Rating	MT
05-07	DA Davidson Raises Price Target on CVS Health to $100 From $80, Keeps Buy/Add Rating	MT
05-07	Truist Adjusts Price Target on CVS Health to $102 From $98, Maintains Buy Rating	MT
05-05	HSBC Adjusts Price Target on CVS Health to $85 From $83, Maintains Hold Rating	MT
04-15	Baird Adjusts CVS Health Price Target to $94 From $92, Maintains Outperform Rating	MT
03-31	Piper Sandler Adjusts Price Target on CVS Health to $99 From $101, Maintains Overweight Rating	MT
03-12	Bernstein Upgrades CVS Health to Outperform From Market Perform, Adjusts Price Target to $94 From $91	MT
03-02	Wolfe Research Adjusts Price Target on CVS Health to $97 From $100, Maintains Outperform Rating	MT
02-12	Goldman Sachs Adjusts Price Target on CVS Health to $97 From $95, Maintains Buy Rating	MT
01-28	Argus Research Adjusts CVS Health Price Target to $90 From $91, Maintains Buy Rating	MT
01-27	CVS Health's Results Likely to Support Long-Term Thesis of HCB Margin Improvement, Capital Deployment, UBS Says	MT
12-17	JPMorgan Adjusts Price Target on CVS Health to $101 From $93, Maintains Overweight Rating	MT
12-12	Bernstein Adjusts CVS Health Price Target to $87 From $86, Maintains Market Perform Rating	MT
12-10	CVS Health Entering 2026 With Momentum and Visibility Into Mid-Teens EPS Growth Through 2028, RBC Says	MT
12-10	CVS Health Lifts Long-Term Growth Targets on PCW Profitability, Turnaround Progress, Morgan Stanley Says	MT
12-10	Piper Sandler Adjusts PT on CVS Health to $101 From $99, Maintains Overweight Rating	MT
12-10	UBS Adjusts Price Target on CVS Health to $97 From $96, Maintains Buy Rating	MT